Selected research
Industry Research
Fludeoxyglucose F 18 Injection Industry Research Report 2026
Market perspective
The global Fludeoxyglucose F 18 Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Fludeoxyglucose F 18 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Fludeoxyglucose F 18 Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Fludeoxyglucose F 18 Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Fludeoxyglucose F 18 Injection include China Isotope & Radiation Corporation, Hta Co., Ltd, Yantai Dongcheng Biochemicals Co.,Ltd., Shanghai Atom Kexing Pharmaceutical Co.,Ltd., HUAYI Technology, Guangdong Cyclotron Medical Science Co., Ltd, Siemens(PETNet) and Isologic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Fludeoxyglucose F 18 Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fludeoxyglucose F 18 Injection Market by Company
China Isotope & Radiation Corporation
Hta Co., Ltd
Yantai Dongcheng Biochemicals Co.,Ltd.
Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
HUAYI Technology
Guangdong Cyclotron Medical Science Co., Ltd
Siemens(PETNet)
Isologic
Fludeoxyglucose F 18 Injection Segment by Type
＜200 mCi/1mL
＞300 mCi/1mL
200-300 mCi/1mL
Fludeoxyglucose F 18 Injection Segment by Application
Heart Disease
Epilepsy
Cancer
Fludeoxyglucose F 18 Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fludeoxyglucose F 18 Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fludeoxyglucose F 18 Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fludeoxyglucose F 18 Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Fludeoxyglucose F 18 Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Fludeoxyglucose F 18 Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Fludeoxyglucose F 18 Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ＜200 mCi/1mL
- ＞300 mCi/1mL
- 200-300 mCi/1mL
Applications
- Heart Disease
- Epilepsy
- Cancer
Companies covered
- China Isotope & Radiation Corporation
- Hta Co., Ltd
- Yantai Dongcheng Biochemicals Co.,Ltd.
- Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
- HUAYI Technology
- Guangdong Cyclotron Medical Science Co., Ltd
- Siemens(PETNet)
- Isologic
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Fludeoxyglucose F 18 Injection Market Size (2021-2032)
- 2.2.2 Global Fludeoxyglucose F 18 Injection Sales (2021-2032)
- 2.2.3 Global Fludeoxyglucose F 18 Injection Market Average Price (2021-2032)
- 2.3 Fludeoxyglucose F 18 Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 ＜200 mCi/1mL
- 2.3.3 ＞300 mCi/1mL
- 2.3.4 200-300 mCi/1mL
- 2.4 Fludeoxyglucose F 18 Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Heart Disease
- 2.4.3 Epilepsy
- 2.4.4 Cancer
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Fludeoxyglucose F 18 Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Fludeoxyglucose F 18 Injection Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Fludeoxyglucose F 18 Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Fludeoxyglucose F 18 Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Fludeoxyglucose F 18 Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Fludeoxyglucose F 18 Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Fludeoxyglucose F 18 Injection, Product Type & Application
- 3.8 Global Manufacturers of Fludeoxyglucose F 18 Injection, Established Date
- 3.9 Global Fludeoxyglucose F 18 Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 China Isotope & Radiation Corporation
- 4.1.1 China Isotope & Radiation Corporation Company Information
- 4.1.2 China Isotope & Radiation Corporation Business Overview
- 4.1.3 China Isotope & Radiation Corporation Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 China Isotope & Radiation Corporation Fludeoxyglucose F 18 Injection Product Portfolio
- 4.1.5 China Isotope & Radiation Corporation Recent Developments
- 4.2 Hta Co., Ltd
- 4.2.1 Hta Co., Ltd Company Information
- 4.2.2 Hta Co., Ltd Business Overview
- 4.2.3 Hta Co., Ltd Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hta Co., Ltd Fludeoxyglucose F 18 Injection Product Portfolio
- 4.2.5 Hta Co., Ltd Recent Developments
- 4.3 Yantai Dongcheng Biochemicals Co.,Ltd.
- 4.3.1 Yantai Dongcheng Biochemicals Co.,Ltd. Company Information
- 4.3.2 Yantai Dongcheng Biochemicals Co.,Ltd. Business Overview
- 4.3.3 Yantai Dongcheng Biochemicals Co.,Ltd. Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Yantai Dongcheng Biochemicals Co.,Ltd. Fludeoxyglucose F 18 Injection Product Portfolio
- 4.3.5 Yantai Dongcheng Biochemicals Co.,Ltd. Recent Developments
- 4.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
- 4.4.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information
- 4.4.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Business Overview
- 4.4.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Fludeoxyglucose F 18 Injection Product Portfolio
- 4.4.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments
- 4.5 HUAYI Technology
- 4.5.1 HUAYI Technology Company Information
- 4.5.2 HUAYI Technology Business Overview
- 4.5.3 HUAYI Technology Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 HUAYI Technology Fludeoxyglucose F 18 Injection Product Portfolio
- 4.5.5 HUAYI Technology Recent Developments
- 4.6 Guangdong Cyclotron Medical Science Co., Ltd
- 4.6.1 Guangdong Cyclotron Medical Science Co., Ltd Company Information
- 4.6.2 Guangdong Cyclotron Medical Science Co., Ltd Business Overview
- 4.6.3 Guangdong Cyclotron Medical Science Co., Ltd Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Guangdong Cyclotron Medical Science Co., Ltd Fludeoxyglucose F 18 Injection Product Portfolio
- 4.6.5 Guangdong Cyclotron Medical Science Co., Ltd Recent Developments
- 4.7 Siemens(PETNet)
- 4.7.1 Siemens(PETNet) Company Information
- 4.7.2 Siemens(PETNet) Business Overview
- 4.7.3 Siemens(PETNet) Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Siemens(PETNet) Fludeoxyglucose F 18 Injection Product Portfolio
- 4.7.5 Siemens(PETNet) Recent Developments
- 4.8 Isologic
- 4.8.1 Isologic Company Information
- 4.8.2 Isologic Business Overview
- 4.8.3 Isologic Fludeoxyglucose F 18 Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Isologic Fludeoxyglucose F 18 Injection Product Portfolio
- 4.8.5 Isologic Recent Developments
5 Global Fludeoxyglucose F 18 Injection Market Scenario by Region
- 5.1 Global Fludeoxyglucose F 18 Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Fludeoxyglucose F 18 Injection Sales by Region: 2021-2032
- 5.2.1 Global Fludeoxyglucose F 18 Injection Sales by Region: 2021-2026
- 5.2.2 Global Fludeoxyglucose F 18 Injection Sales by Region: 2027-2032
- 5.3 Global Fludeoxyglucose F 18 Injection Revenue by Region: 2021-2032
- 5.3.1 Global Fludeoxyglucose F 18 Injection Revenue by Region: 2021-2026
- 5.3.2 Global Fludeoxyglucose F 18 Injection Revenue by Region: 2027-2032
- 5.4 North America Fludeoxyglucose F 18 Injection Market Facts & Figures by Country
- 5.4.1 North America Fludeoxyglucose F 18 Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Fludeoxyglucose F 18 Injection Sales by Country (2021-2032)
- 5.4.3 North America Fludeoxyglucose F 18 Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Fludeoxyglucose F 18 Injection Market Facts & Figures by Country
- 5.5.1 Europe Fludeoxyglucose F 18 Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Fludeoxyglucose F 18 Injection Sales by Country (2021-2032)
- 5.5.3 Europe Fludeoxyglucose F 18 Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Fludeoxyglucose F 18 Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Fludeoxyglucose F 18 Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Fludeoxyglucose F 18 Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Fludeoxyglucose F 18 Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Fludeoxyglucose F 18 Injection Market Facts & Figures by Country
- 5.7.1 South America Fludeoxyglucose F 18 Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Fludeoxyglucose F 18 Injection Sales by Country (2021-2032)
- 5.7.3 South America Fludeoxyglucose F 18 Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Fludeoxyglucose F 18 Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Fludeoxyglucose F 18 Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Fludeoxyglucose F 18 Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Fludeoxyglucose F 18 Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Fludeoxyglucose F 18 Injection Sales by Type (2021-2032)
- 6.1.1 Global Fludeoxyglucose F 18 Injection Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Fludeoxyglucose F 18 Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Fludeoxyglucose F 18 Injection Revenue by Type (2021-2032)
- 6.2.1 Global Fludeoxyglucose F 18 Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Fludeoxyglucose F 18 Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Fludeoxyglucose F 18 Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Fludeoxyglucose F 18 Injection Sales by Application (2021-2032)
- 7.1.1 Global Fludeoxyglucose F 18 Injection Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Fludeoxyglucose F 18 Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Fludeoxyglucose F 18 Injection Revenue by Application (2021-2032)
- 7.2.1 Global Fludeoxyglucose F 18 Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Fludeoxyglucose F 18 Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Fludeoxyglucose F 18 Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Fludeoxyglucose F 18 Injection Value Chain Analysis
- 8.1.1 Fludeoxyglucose F 18 Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Fludeoxyglucose F 18 Injection Production Mode & Process
- 8.2 Fludeoxyglucose F 18 Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Fludeoxyglucose F 18 Injection Distributors
- 8.2.3 Fludeoxyglucose F 18 Injection Customers
9 Global Fludeoxyglucose F 18 Injection Analyzing Market Dynamics
- 9.1 Fludeoxyglucose F 18 Injection Industry Trends
- 9.2 Fludeoxyglucose F 18 Injection Industry Drivers
- 9.3 Fludeoxyglucose F 18 Injection Industry Opportunities and Challenges
- 9.4 Fludeoxyglucose F 18 Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst